NDC 68382-913 – Erlotinib
Erlotinib Hydrochloride 25 mg/1 · Tablet · Oral
Product NDC68382-913
Product details
- Brand name
- Erlotinib
- Generic name
- Erlotinib
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA213065
- Marketed since
- April 30, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Erlotinib Hydrochloride 25 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 68382-913-06 | 30 TABLET in 1 BOTTLE (68382-913-06) | Apr 30, 2020 |
| 68382-913-16 | 90 TABLET in 1 BOTTLE (68382-913-16) | Apr 30, 2020 |
| 68382-913-84 | 3 BLISTER PACK in 1 CARTON (68382-913-84) / 10 TABLET in 1 BLISTER PACK (68382-913-30) | Apr 30, 2020 |
Other Erlotinib products
- 68382-915 Erlotinib Hydrochloride 150 mg/1 · Tablet · Zydus Pharmaceuticals USA Inc.
- 68382-914 Erlotinib Hydrochloride 100 mg/1 · Tablet · Zydus Pharmaceuticals USA Inc.
- 72485-219 Erlotinib Hydrochloride 150 mg/1 · Tablet, Film Coated · Armas Pharmaceuticals Inc.
- 72485-218 Erlotinib Hydrochloride 100 mg/1 · Tablet, Film Coated · Armas Pharmaceuticals Inc.
- 72485-217 Erlotinib Hydrochloride 25 mg/1 · Tablet, Film Coated · Armas Pharmaceuticals Inc.
- 59651-530 Erlotinib Hydrochloride 25 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-531 Erlotinib Hydrochloride 100 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-532 Erlotinib Hydrochloride 150 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 31722-263 Erlotinib Hydrochloride 25 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-264 Erlotinib Hydrochloride 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-265 Erlotinib Hydrochloride 150 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 63304-096 Erlotinib 100 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.